C. S. Brian Chia

1.3k total citations
41 papers, 931 citations indexed

About

C. S. Brian Chia is a scholar working on Molecular Biology, Microbiology and Infectious Diseases. According to data from OpenAlex, C. S. Brian Chia has authored 41 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Microbiology and 12 papers in Infectious Diseases. Recurrent topics in C. S. Brian Chia's work include Antimicrobial Peptides and Activities (15 papers), Biochemical and Structural Characterization (11 papers) and Mosquito-borne diseases and control (9 papers). C. S. Brian Chia is often cited by papers focused on Antimicrobial Peptides and Activities (15 papers), Biochemical and Structural Characterization (11 papers) and Mosquito-borne diseases and control (9 papers). C. S. Brian Chia collaborates with scholars based in Singapore, Australia and France. C. S. Brian Chia's co-authors include Jeffrey Hill, CongBao Kang, Fui Mee Ng, Joma Joy, Anders Poulsen, Alvin W. Hung, John H. Bowie, Melgious Jin Yan Ang, Xiao Han and Matthew A. Cooper and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Scientific Reports.

In The Last Decade

C. S. Brian Chia

41 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. S. Brian Chia Singapore 17 405 248 209 178 153 41 931
Benjamin U. Samuel United States 16 549 1.4× 470 1.9× 91 0.4× 60 0.3× 98 0.6× 22 1.3k
M. Yogavel India 19 724 1.8× 286 1.2× 120 0.6× 92 0.5× 24 0.2× 66 1.3k
E. Schmitt Switzerland 21 744 1.8× 159 0.6× 142 0.7× 48 0.3× 71 0.5× 28 1.3k
Karina Persson Sweden 19 706 1.7× 227 0.9× 88 0.4× 57 0.3× 59 0.4× 48 1.3k
Pauline Machebœuf France 12 539 1.3× 169 0.7× 209 1.0× 45 0.3× 146 1.0× 16 1.1k
Christiane Deregnaucourt France 17 373 0.9× 213 0.9× 56 0.3× 47 0.3× 48 0.3× 27 847
Michael B. Harbut United States 11 462 1.1× 242 1.0× 150 0.7× 38 0.2× 49 0.3× 13 915
John Allocco United States 14 597 1.5× 273 1.1× 105 0.5× 38 0.2× 35 0.2× 17 1.1k
Sandra J. Darkin‐Rattray United States 13 763 1.9× 168 0.7× 92 0.4× 55 0.3× 38 0.2× 18 1.1k
Hao Lu China 16 410 1.0× 57 0.2× 245 1.2× 128 0.7× 18 0.1× 40 881

Countries citing papers authored by C. S. Brian Chia

Since Specialization
Citations

This map shows the geographic impact of C. S. Brian Chia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. Brian Chia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. Brian Chia more than expected).

Fields of papers citing papers by C. S. Brian Chia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. Brian Chia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. Brian Chia. The network helps show where C. S. Brian Chia may publish in the future.

Co-authorship network of co-authors of C. S. Brian Chia

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. Brian Chia. A scholar is included among the top collaborators of C. S. Brian Chia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. Brian Chia. C. S. Brian Chia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chia, C. S. Brian. (2022). A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads. ChemMedChem. 17(11). e202200032–e202200032. 39 indexed citations
2.
Liu, Bo, Yi Yang See, Gang Wang, et al.. (2021). A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors. Bioorganic & Medicinal Chemistry Letters. 48. 128263–128263. 18 indexed citations
3.
Li, Jianguo, Marc‐Antoine Sani, Yan Li, et al.. (2018). Elucidating the bactericidal mechanism of action of the linear antimicrobial tetrapeptide BRBR-NH2. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1860(8). 1517–1527. 14 indexed citations
4.
Ng, Fui Mee, Timothy Barkham, Jeanette Teo, et al.. (2018). Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans. European Journal of Medicinal Chemistry. 150. 479–490. 18 indexed citations
5.
Ng, Fui Mee, et al.. (2017). Preliminary investigations into developing all‐D Omiganan for treating Mupirocin‐resistant MRSA skin infections. Chemical Biology & Drug Design. 90(6). 1155–1160. 22 indexed citations
6.
Ng, Fui Mee, et al.. (2017). Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections. European Journal of Clinical Microbiology & Infectious Diseases. 37(1). 141–148. 33 indexed citations
7.
Tan, Yong Wah, Melgious Jin Yan Ang, Anders Poulsen, et al.. (2016). Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease. Scientific Reports. 6(1). 33663–33663. 15 indexed citations
8.
Chu, Justin Jang Hann, Regina Ching Hua Lee, Melgious Jin Yan Ang, et al.. (2015). Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay. Antiviral Research. 118. 68–74. 40 indexed citations
9.
Ng, Fui Mee, et al.. (2015). Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure–activity relationship study. European Journal of Medicinal Chemistry. 105. 138–144. 28 indexed citations
10.
Ng, Fui Mee, Anders Poulsen, Wei-Guang Seetoh, et al.. (2015). Application of Fragment‐Based Drug Discovery against DNA Gyrase B. ChemPlusChem. 80(8). 1250–1254. 12 indexed citations
11.
Ang, Melgious Jin Yan, et al.. (2013). Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: A P3 and N-cap optimization study. European Journal of Medicinal Chemistry. 62. 199–205. 16 indexed citations
12.
Ang, Melgious Jin Yan, Anders Poulsen, Zhitao Li, et al.. (2013). Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: A P1–P4 SAR study. European Journal of Medicinal Chemistry. 68. 72–80. 2 indexed citations
13.
Ang, Melgious Jin Yan, Zhitao Li, Fui Mee Ng, et al.. (2013). A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B/NS3 protease using C-terminal agmatine dipeptides. Peptides. 52. 49–52. 6 indexed citations
14.
Kim, Youngmee, Shovanlal Gayen, CongBao Kang, et al.. (2013). NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex. Journal of Biological Chemistry. 288(18). 12891–12900. 90 indexed citations
15.
Kang, CongBao, Shovanlal Gayen, Weiling Wang, et al.. (2012). Exploring the binding of peptidic West Nile virus NS2B–NS3 protease inhibitors by NMR. Antiviral Research. 97(2). 137–144. 27 indexed citations
16.
Joy, Joma, et al.. (2011). Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease. European Journal of Medicinal Chemistry. 46(7). 3130–3134. 26 indexed citations
17.
Schüller, Andreas, Zheng Yin, C. S. Brian Chia, et al.. (2011). Tripeptide inhibitors of dengue and West Nile virus NS2B–NS3 protease. Antiviral Research. 92(1). 96–101. 79 indexed citations
18.
Kang, CongBao, et al.. (2010). Solid-Phase Synthesis and NMR Structural Studies of the Marine Antibacterial Cyclic Tetrapeptide: Cyclo[GSPE]. International Journal of Peptide Research and Therapeutics. 16(3). 145–152. 13 indexed citations
19.
Brown, Christopher J., Jaehong Lim, Thomas A. Leonard, et al.. (2010). Stabilizing the eIF4G1 α-Helix Increases Its Binding Affinity with eIF4E: Implications for Peptidomimetic Design Strategies. Journal of Molecular Biology. 405(3). 736–753. 16 indexed citations
20.
Chia, C. S. Brian, Yujing Gong, John H. Bowie, Johannes Zuegg, & Matthew A. Cooper. (2010). Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatin. Biopolymers. 96(2). 147–157. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin U. Samuel Breakdown of academic impact, for papers by M. Yogavel Breakdown of academic impact, for papers by E. Schmitt Breakdown of academic impact, for papers by Karina Persson Breakdown of academic impact, for papers by Pauline Machebœuf Breakdown of academic impact, for papers by Christiane Deregnaucourt Breakdown of academic impact, for papers by Michael B. Harbut Breakdown of academic impact, for papers by John Allocco Breakdown of academic impact, for papers by Sandra J. Darkin‐Rattray Breakdown of academic impact, for papers by Hao Lu
Rankless by CCL
2026